Caricamento...
The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
BACKGROUND: Chloroquine, a quinolone antimalarial drug, is known to potentially inhibit pH-dependent viral replication of the SARS-CoV‑2 infection. Therefore, chloroquine is considered as a treatment option for coronavirus disease 2019 (COVID-19). Chloroquine is known for prolonging the QT interval,...
Salvato in:
| Pubblicato in: | Neth Heart J |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bohn Stafleu van Loghum
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7346846/ https://ncbi.nlm.nih.gov/pubmed/32648153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-020-01462-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|